OAC
GLUE icon

OMERS Administration Corp’s Monte Rosa Therapeutics GLUE Stock Holding History

OMERS Administration Corp’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$446K Buy
+27,100
New +$518K ﹤0.01% 777
2025
Q4 		– Sell
-28,300
Closed -$210K – 1171
2025
Q3 		$210K Buy
+28,300
New +$150K ﹤0.01% 974

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

OMERS Administration Corp's GLUE Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Monte Rosa Therapeutics (GLUE) in Q1 2026: 27,100 shares worth $446K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in GLUE as recently as Q3 2025.

OMERS Administration Corp first reported a position in GLUE in Q3 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • OMERS Administration Corp held 27,100 shares of Monte Rosa Therapeutics worth $446K as of Q1 2026.
  • Monte Rosa Therapeutics was a new OMERS Administration Corp position in Q1 2026.
  • Monte Rosa Therapeutics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #777 holding.
  • OMERS Administration Corp first reported a position in Monte Rosa Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.